Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Infectious Diseases|August 1, 1996
Once-weekly intraocular injections of ganciclovir for maintenance therapy of cytomegalovirus retinitis: clinical and ocular outcomeW G Hodge, R G Lalonde, J Sampalis, et al.
Sexually Transmitted Diseases|July 1, 1983
Comparison of rosaramicin and erythromycin stearate for treatment of cervical infection with Chlamydia trachomatisH G Robson, P P Shah, R G Lalonde, et al.
Tissue Antigens|October 22, 2009
Successful implementation of a national HLA-B*5701 genetic testing service in CanadaR G Lalonde, R Thomas, A Rachlis, et al.
HIV Medicine|October 4, 2003
Interleukin-7 levels may predict virological response in advanced HIV-1-infected patients receiving lopinavir/ritonavir-based therapyM R Boulassel, G H R Smith, N Gilmore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 1998
Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study GroupS D Shafran, J A Talbot, S Chomyc, et al.
HIV Medicine|July 14, 2005
Influence of RANTES, SDF-1 and TGF-beta levels on the value of interleukin-7 as a predictor of virological response in HIV-1-infected patients receiving double boosted protease inhibitor-based therapyM R Boulassel, G H R Smith, M D de B Edwardes, et al.
The New England Journal of Medicine|August 8, 1996
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study GroupS D Shafran, J Singer, D P Zarowny, et al.
Pageof 2